a developer of patient-specific expanded cellular therapies for use in the treatment of patients with diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, VCEL has been loosely correlated with BEAM. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if VCEL jumps, then BEAM could also see price increases.
Ticker / NAME | Correlation To VCEL | 1D Price Change % | ||
---|---|---|---|---|
VCEL | 100% | -0.75% | ||
BEAM - VCEL | 45% Loosely correlated | -1.57% | ||
SNDX - VCEL | 43% Loosely correlated | +2.59% | ||
DNLI - VCEL | 42% Loosely correlated | -0.87% | ||
NTLA - VCEL | 42% Loosely correlated | -3.24% | ||
ALEC - VCEL | 41% Loosely correlated | -7.66% | ||
More |
Ticker / NAME | Correlation To VCEL | 1D Price Change % |
---|---|---|
VCEL | 100% | -0.75% |
treatment theme (56 stocks) | 53% Loosely correlated | -1.12% |
stem cells theme (21 stocks) | 53% Loosely correlated | -3.58% |
medical research theme (126 stocks) | 47% Loosely correlated | -2.00% |
medical service theme (154 stocks) | 45% Loosely correlated | -2.06% |
cellular theme (5 stocks) | 28% Poorly correlated | -2.41% |